Evidence map›Paper›PMID 19255442›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

LOK is a major ERM kinase in resting lymphocytes and regulates cytoskeletal rearrangement through ERM phosphorylation.

Natalya V Belkina, Yin Liu, Jian-Jiang Hao, Hajime Karasuyama, Stephen Shaw

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 152 citations in OpenAlex.

  1. Article
  2. Article
  3. ERM Inhibition Confers Ferroptosis Resistance through ROS-Induced NRF2 Signaling.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. CRABP1-complexes in exosome secretion.Cell communication and signaling : CCS · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Natalya V BelkinaExperimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Yin Liu
Jian-Jiang Hao
Hajime Karasuyama
Stephen Shaw
National Institutes of Health · USNational Cancer Institute · USTokyo Medical and Dental University · JP

Funding

Application of Flow Cytometry to Cell BiologyZICBC009255 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CROSSMAN, ASSIATU · 2009 to 2025
$26.4M
APPLICATION OF FLOW CYTOMETRY TO CELL BIOLOGYZ01BC009255 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SHARROW, SUSAN · 1996 to 2008
$3.0M
ERM phosphorylation in lymphocytesZIABC010995 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SHAW, JAMES · 2009 to 2012
$1.2M
Lymphocyte membrane-proximal basophilic kinasesZIABC010994 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SHAW, JAMES · 2009 to 2012
$472k
ERM phosphorylation in lymphocytesZ01BC010995 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SHAW, JAMES · 2008 to 2008
$383k
Lymphocyte membrane-proximal basophilic kinasesZ01BC010994 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SHAW, JAMES · 2008 to 2008
$326k
6 · The paper itself

Abstract

ERM (ezrin-radixin-moesin) proteins mediate linkage of actin cytoskeleton to plasma membrane in many cells. ERM activity is regulated in part by phosphorylation at a C-terminal threonine, but the identity of ERM kinases is unknown in lymphocytes and incompletely defined in other mammalian cells. Our studies show that lymphocyte-oriented kinase (LOK) is an ERM kinase in vitro and in vivo. Mass spectrometric analysis indicates LOK is abundant at the lymphocyte plasma membrane and immunofluorescence studies show LOK enrichment at the plasma membrane near ERM. In vitro peptide specificity analyses characterize LOK as a basophilic kinase whose optimal substrate sequence resembles the ERM site, including unusual preference for tyrosine at P-2. LOK's activity on moesin peptide and protein was comparable to reported ERM kinases ROCK and PKC but unlike them LOK displayed preferential specificity for moesin compared to traditional basophilic kinase substrates. Two genetic approaches demonstrate a role for LOK in ERM phosphorylation: cell transfection with LOK kinase domain augments ERM phosphorylation and lymphocytes from LOK knockout mice have >50% reduction in ERM phosphorylation. The findings on localization and specificity argue that LOK is a direct ERM kinase. The knockout mice have normal hematopoietic cell development but notably lymphocyte migration and polarization in response to chemokine are enhanced. These functional alterations fit the current understanding of the role of ERM phosphorylation in regulating cortical reorganization. Thus, these studies identify a new ERM kinase of importance in lymphocytes and confirm the role of ERM phosphorylation in regulating cell shape and motility.

Indexed as

Amino Acid SequenceAnimalsCell MembraneCell PolarityChemokinesChemotaxisCytoskeletal ProteinsCytoskeletonEzrinHumansJurkat CellsLymphocytesMembrane ProteinsMiceMice, KnockoutMicrofilament ProteinsChemokinesCytoskeletal ProteinsEzrinMembrane ProteinsMicrofilament ProteinsmoesinPeptidesProtein Serine-Threonine KinasesradixinSTK10 protein, humanStk10 protein, mouse

Identifiers

PMID19255442
PMCPMC2660762
OpenAlexW2053446635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.